A detailed history of Rwc Asset Management LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Rwc Asset Management LLP holds 1,731 shares of ABT stock, worth $220,927. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,731
Previous 1,772 2.31%
Holding current value
$220,927
Previous $235,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$123.95 - $138.08 $5,081 - $5,661
-41 Reduced 2.31%
1,731 $235,000
Q1 2025

May 07, 2025

BUY
$111.1 - $140.22 $196,869 - $248,469
1,772 New
1,772 $235,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rwc Asset Management LLP Portfolio

Follow Rwc Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rwc Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Rwc Asset Management LLP with notifications on news.